STAT+: FDA warns more telehealth firms about compounded GLP-1s

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Moderna is avoiding what would have been a high-profile trial, but will still have to pay up. That and more news below. Let’s get to it...

🔗 Read more: https://www.statnews.com/2026/03/04/biotech-news-fda-warns-telehealth-about-glp-1-compounding/?utm_campaign=rss

#News #Biotech #Tech #Health #Chemistry #Politics #Science